These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7683835)

  • 21. Limitations of flow cytometric DNA analysis for the diagnosis of bladder cancer.
    Boileau MA; Swartz D; Schmidt KL; Schmidt WA
    J Surg Oncol; 1989 Mar; 40(3):194-200. PubMed ID: 2918724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
    Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
    J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
    Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O
    J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.
    Critelli R; Fasanelli F; Oderda M; Polidoro S; Assumma MB; Viberti C; Preto M; Gontero P; Cucchiarale G; Lurkin I; Zwarthoff EC; Vineis P; Sacerdote C; Matullo G; Naccarati A
    Oncotarget; 2016 Oct; 7(41):67435-67448. PubMed ID: 27611947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer.
    Murphy WM; Emerson LD; Chandler RW; Moinuddin SM; Soloway MS
    J Urol; 1986 Oct; 136(4):815-9. PubMed ID: 3761437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells.
    Wheeless LL; Reeder JE; O'Connell MJ; Robinson RD; Cosgriff JM; Fradet Y; Frank IN; Cockett AT
    Cytometry; 1991; 12(2):140-6. PubMed ID: 2049971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric DNA analysis after immunoselection of bladder tumor cells with monoclonal antibody DU83.21.
    Wright GL; Alexander JP; Konchuba AM; Schellhammer PF; Schlossberg SM
    Cancer; 1990 Sep; 66(6):1242-52. PubMed ID: 1698117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial.
    Bruno S; Torrisi R; Costantini M; Baglietto L; Fontana V; Gatteschi B; Melioli G; Nicolo G; Curotto A; Malcangi B; Bruttini GP; Varaldo M; Bruzzi P; Decensi A
    J Cell Biochem; 1999 Dec; 76(2):311-21. PubMed ID: 10618647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of mailed urine specimens in diagnosing urothelial carcinoma by cytology and DNA image analysis.
    Liu J; Katz R; Shin HJ; Johnston DA; Zhang HZ; Caraway NP
    Acta Cytol; 2005; 49(2):157-62. PubMed ID: 15839620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
    Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
    J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of cell kinetic characteristics using flow cytometric measurements of deoxyribonucleic acid and bromodeoxyuridine for bladder cancer.
    Tachibana M; Deguchi N; Jitsukawa S; Baba S; Hata M; Tazaki H
    J Urol; 1991 May; 145(5):963-7. PubMed ID: 2016810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells.
    Bonner RB; Hemstreet GP; Fradet Y; Rao JY; Min KW; Hurst RE
    Cancer; 1993 Oct; 72(8):2461-9. PubMed ID: 8402463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma.
    Badalament RA; Kimmel M; Gay H; Cibas ES; Whitmore WF; Herr HW; Fair WR; Melamed MR
    Cancer; 1987 Jun; 59(12):2078-85. PubMed ID: 3567868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder transitional cell carcinomas: a comparative study of washing and tumor bioptic samples by DNA flow cytometry and FISH analyses.
    Eleuteri P; Grollino MG; Pomponi D; Guaglianone S; Gallucci M; De Vita R
    Eur Urol; 2000 Mar; 37(3):275-80. PubMed ID: 10720852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical application of flow cytometry in urology. 3. Correlation between urinary cytology and flow cytometry].
    Tachibana M; Nakamura S; Shibayama T; Jitsukawa S; Deguchi N; Baba S; Nakazono M; Hata M; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1986 Nov; 77(11):1864-7. PubMed ID: 3573470
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination of cytologic evaluation and quantitative digital cytometry is reliable in detecting recurrent disease in patients with urinary diversions.
    Caraway NP; Khanna A; Payne L; Kamat AM; Katz RL
    Cancer; 2007 Oct; 111(5):323-9. PubMed ID: 17721991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of DNA flow cytometry as a screening test for bladder cancer.
    deVere White RW; Deitch AD
    J Cell Biochem Suppl; 1992; 16I():80-4. PubMed ID: 1305694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors.
    Grégoire M; Fradet Y; Meyer F; Têtu B; Bois R; Bédard G; Charrois R; Naud A
    J Urol; 1997 May; 157(5):1660-4. PubMed ID: 9112500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytologic evaluation of low grade transitional cell carcinoma and instrument artifact in bladder washings.
    Chu YC; Han JY; Han HS; Kim JM; Suh JK
    Acta Cytol; 2002; 46(2):341-8. PubMed ID: 11917583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
    Hosaka Y
    Nihon Rinsho; 1992 Oct; 50(10):2426-31. PubMed ID: 1447813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.